Literature DB >> 23089292

Construction and characterization of a reporter gene cell line for assessment of human glucocorticoid receptor activation.

Aneta Novotna1, Petr Pavek, Zdenek Dvorak.   

Abstract

Glucocorticoids are widely used drugs in human pharmacotherapy. There is an increasing demand for tools allowing detection of the ligands for glucocorticoid receptor (GR), with regard to pre-clinical drug testing and environmental applications. We constructed human luciferase reporter gene cell line AZ-GR derived from HeLa human cervix carcinoma cells, which were stably transfected with reporter plasmid containing three copies of glucorticoid response element (GRE) upstream of luciferase reporter gene. We isolated five dexamethasone-responsive clones, and we further characterized two most responsive ones (AZ-GR). Dose-response analyses were performed with 22 different natural and synthetic steroids and the values of EC(50) were calculated. AZ-GR cells displayed high specificity and sensitivity to glucocorticoids, very low responsiveness to mineralocorticoids, but no responsiveness to estrogens, gestagens or androgens. Time-course analyses revealed that AZ-GR cells allow detection of GR activators soon after 14 h of the treatment (6-10-fold induction by 100 nM dexamethasone). Functionality of AZ-GR cells was not affected with cryopreservation. Generated reporter gene cell lines fully maintained responsiveness to glucocorticoids for 32 days in the culture and over 16 passages without significant alterations. The sensitivity of the assay allows high throughput format using 96-well plates. Collectively, we present here glucocorticoid-responsive stable reporter gene cell line that allows high throughput, rapid, sensitive and selective detection of GR activators, with possible use in pre-clinical research and environmental applications.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089292     DOI: 10.1016/j.ejps.2012.10.003

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  5 in total

1.  In vitro profiling of toxic effects of prominent environmental lower-chlorinated PCB congeners linked with endocrine disruption and tumor promotion.

Authors:  Kateřina Pěnčíková; Lucie Svržková; Simona Strapáčová; Jiří Neča; Iveta Bartoňková; Zdeněk Dvořák; Martina Hýžďalová; Jakub Pivnička; Lenka Pálková; Hans-Joachim Lehmler; Xueshu Li; Jan Vondráček; Miroslav Machala
Journal:  Environ Pollut       Date:  2018-03-15       Impact factor: 8.071

2.  Omeprazole and lansoprazole enantiomers induce CYP3A4 in human hepatocytes and cell lines via glucocorticoid receptor and pregnane X receptor axis.

Authors:  Aneta Novotna; Zdenek Dvorak
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

3.  Optical Isomers of Atorvastatin, Rosuvastatin and Fluvastatin Enantiospecifically Activate Pregnane X Receptor PXR and Induce CYP2A6, CYP2B6 and CYP3A4 in Human Hepatocytes.

Authors:  Martina Korhonova; Aneta Doricakova; Zdenek Dvorak
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

4.  Enantiospecific effects of ketoconazole on aryl hydrocarbon receptor.

Authors:  Aneta Novotna; Martina Korhonova; Iveta Bartonkova; Anatoly A Soshilov; Michael S Denison; Katerina Bogdanova; Milan Kolar; Petr Bednar; Zdenek Dvorak
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

5.  Targeting the pregnane X receptor using microbial metabolite mimicry.

Authors:  Zdeněk Dvořák; Felix Kopp; Hao Li; Aneta Vrzalová; Cait M Costello; Jazmin S Kemp; Martina Štěpánková; Iveta Bartoňková; Eva Jiskrová; Karolína Poulíková; Barbora Vyhlídalová; Lars U Nordstroem; Chamini V Karunaratne; Harmit S Ranhotra; Kyu Shik Mun; Anjaparavanda P Naren; Iain A Murray; Gary H Perdew; Julius Brtko; Lucia Toporova; Arne Schön; Bret D Wallace; William G Walton; Matthew R Redinbo; Katherine Sun; Amanda Beck; Sandhya Kortagere; Michelle C Neary; Aneesh Chandran; Saraswathi Vishveshwara; Maria M Cavalluzzi; Giovanni Lentini; Julia Yue Cui; Haiwei Gu; John C March; Shirshendu Chatterjee; Adam Matson; Dennis Wright; Kyle L Flannigan; Simon A Hirota; Ryan Balfour Sartor; Sridhar Mani
Journal:  EMBO Mol Med       Date:  2020-03-10       Impact factor: 12.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.